Low-dose Pfizer-BioNTech vaccine fails in trial on 2 to 5 year olds
Newly released data by Pfizer presents a worrying omen for getting younger children vaccinated against Covid.
A low dose of the Pfizer-BioNTech coronavirus vaccine failed to produce an adequate response in children aged two to five years of age.
The companies announced the results from ongoing critical trials on Friday and said that after testing children 6 months to 5 years of age with one-tenth of the adult dose, children between 6 months and 2 years produced an immune response similar to people aged 16 to 25 after two doses but children between 2 and 5 did not.
“The companies will amend the clinical study evaluating the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age,” the statement said. ”The study will now include evaluating a third dose of 3 µg at least two months after the second dose of the two-dose series to provide high levels of protection in this young age group.”
The companies said if the three-dose study is successful, they plan to apply for emergency authorisation sometime in the first half of 2022.
A kid-sized version of Pfizer’s vaccine already is available for 5 to 11-year-olds, one that’s a third of the dose given to everyone else 12 and older.
No safety concerns have been spotted in the study, the companies said.
Pfizer vaccine research chief Kathrin Jansen cited other data showing a booster shot for people 16 and older restores strong protection, a jump in immunity that scientists hope also will help fend off the new omicron variant.
More Coverage
The companies also are preparing to test a booster for 5- to 11-year-olds, who are just now getting their two-dose vaccinations. And they are testing different dose options for teen boosters.
Jansen said if the additional paediatric testing is successful, “we would have a consistent three-dose vaccine approach for all ages.”
This story originally appeared on Fox News and is republished here with permission.
‘Harm’: Doctors demand Covid vaccine pulled
A petition calling for Covid vaccines to be pulled has attracted high-profile backers — including one of Donald Trump’s key appointments.
Big move as new Covid variants spread
Australians could soon be eligible for two new Covid vaccines, created to protect against new strains of the virus.
‘Alarming’ virus surge erupts in one state
One Aussie state has been whacked by a sudden and “alarming” surge in virus cases that are surpassing Covid-19 hospitalisations.